Survival Related to Treatment of Patients with Metastatic Neuroendocrine Lung Tumors Treated in a Brazilian Center
Introduction: Well-differentiated Neuroendocrine Pulmonary Tumors (NETp) are morphologically classified as Typical (TC) and Atypical Carcinoid (AC).
Aim(s): There are few data on systemic treatment outcomes according to cell morphology.
Materials and methods: We selected consecutive metastatic patients (pts) with TC or AC treated from 2002 to 2019. All Pts selected had a confirmed diagnosis of TC or AC and received at least one treatment modality (e.g. somatostatin analogue [SSA], chemotherapy [ChT] and everolimus [Eve]). Variables were analyzed with the chi-square test and median progression-free survival (mPFS) in months, the primary endpoint, with the Kaplan-Meyer method.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Tanaka H
To read the full abstract, please log into your ENETS Member account.